Department of Pharmaceutical and Health Economics, School of Pharmacy, Leonard D. Schaeffer Center for Health Policy and Economics, University of Southern California, Los Angeles.
Synergy Pharmacy Solutions, Bakersfield, CA.
Med Care. 2021 Jun 1;59(6):519-527. doi: 10.1097/MLR.0000000000001520.
Evaluate the impact of pharmacist-provided transition of care (TOC) services on hospital readmissions.
Starting March 2014, TOC services were provided to all hospitalized patients from an at-risk medical group. Data covering all inpatient and outpatient services and prescription drugs were retrieved for all adult patients discharged between January 2010 and December 2018. The overall impact of TOC was estimated using a generalized estimating equation with logistic regression. Longitudinal TOC effects were estimated using generalized estimating equation in an interrupted time series model. Parallel analyses were conducted using data from an affiliated medical group in a neighboring county without access to the TOC intervention.
The study included 13,256 hospital discharges for adult patients for the 30-day readmission analysis and 10,740 discharges for the 180 days analysis. The TOC program reduced 30-day readmission risk by 34.9% [odds ratio (OR)=0.651 (range, 0.590-0.719)] and 180-day readmissions by 33.4% [OR=0.666 (range, 0.604-0.735)]. The interrupted time series results found the 30-day readmission rate to be stable over the pre-TOC period (OR=0.00; not significant) then to decreased by 1.5% per month in the post-TOC period [OR=0.985 (range, 0.980-0.991)]. For 180-day readmissions, risk decreased by 1% per month after TOC implementation [OR=0.990 (range, 0.984-0.996)]. Referral to the medical group's pre-existing Priority Care clinic also reduced readmission risk. Results from the comparison medical group found 180-day readmission declined by 1% per month after March 2014 [OR=0.990 (0.891-1.00)].
Adding a pharmacist-led TOC program to the medical group's existing outpatient services reduced 30- and 180-day readmissions by "bending the curve" for readmission risk over time.
评估药剂师提供的过渡护理(TOC)服务对医院再入院的影响。
自 2014 年 3 月起,向高危医疗组的所有住院患者提供 TOC 服务。检索了 2010 年 1 月至 2018 年 12 月期间所有成年患者的所有住院和门诊服务以及处方药数据。使用逻辑回归的广义估计方程估计 TOC 的总体影响。使用广义估计方程在中断时间序列模型中估计纵向 TOC 效应。使用邻近县的一个附属医疗集团的数据进行平行分析,该集团无法获得 TOC 干预措施。
研究包括 13256 例成人患者 30 天再入院分析和 10740 例 180 天分析的出院患者。TOC 计划将 30 天再入院风险降低了 34.9%[比值比(OR)=0.651(范围,0.590-0.719)],将 180 天再入院风险降低了 33.4%[OR=0.666(范围,0.604-0.735)]。中断时间序列结果发现,在 TOC 前期间,30 天再入院率保持稳定(OR=0.00;不显著),然后在 TOC 后期间每月下降 1.5%[OR=0.985(范围,0.980-0.991)]。对于 180 天的再入院,在 TOC 实施后,风险每月降低 1%[OR=0.990(范围,0.984-0.996)]。转介到医疗集团现有的优先护理诊所也降低了再入院风险。来自比较医疗集团的结果发现,2014 年 3 月后,180 天的再入院率每月下降 1%[OR=0.990(0.891-1.00)]。
在医疗集团现有的门诊服务中增加由药剂师主导的 TOC 计划,通过随时间“弯曲”再入院风险曲线,降低了 30 天和 180 天的再入院率。